BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2952418)

  • 1. Lens metabolism and cellular effects of aldose reductase.
    McLean P; Gonzalez AM; Sochor M; Hothersall JS
    Diabet Med; 1985 May; 2(3):189-93. PubMed ID: 2952418
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of M79175, an aldose reductase inhibitor, on experimental sugar cataracts].
    Ono H; Nozawa Y; Hayano S
    Nippon Ganka Gakkai Zasshi; 1982; 86(9):1343-50. PubMed ID: 6818854
    [No Abstract]   [Full Text] [Related]  

  • 3. Aldose reductase in diabetic cataracts.
    Kinoshita JH; Kador P; Catiles M
    JAMA; 1981 Jul; 246(3):257-61. PubMed ID: 6787220
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of high glucose and oxidative stress on lens metabolism, aldose reductase, and senile cataractogenesis.
    Cheng HM; González RG
    Metabolism; 1986 Apr; 35(4 Suppl 1):10-4. PubMed ID: 3083198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raman spectroscopic study of the effect of aldose reductase inhibitor on experimental diabetic cataract.
    Nozawa H; Yaginuma T; Mizuno A
    Nippon Ganka Gakkai Zasshi; 1988 Jan; 92(1):194-201. PubMed ID: 3133929
    [No Abstract]   [Full Text] [Related]  

  • 6. Nonosmotic diabetic cataracts.
    Malone JI; Lowitt S; Cook WR
    Pediatr Res; 1990 Mar; 27(3):293-6. PubMed ID: 2138728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of aldose reductase and its inhibition on sugar cataract formation.
    Kador PF; Akagi Y; Kinoshita JH
    Metabolism; 1986 Apr; 35(4 Suppl 1):15-9. PubMed ID: 3083204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of diabetic cataract by sorbinil, an aldose reductase inhibitor.
    Beyer-Mears A; Cruz E
    Diabetes; 1985 Jan; 34(1):15-21. PubMed ID: 3917257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic cataracts in animal models: prevention and reversibility with aldose reductase inhibitors.
    Kador PF; Akagi Y; Kinoshita JH
    Diabet Med; 1985 May; 2(3):194-6. PubMed ID: 2952419
    [No Abstract]   [Full Text] [Related]  

  • 10. Cataract prevention in diabetic Octodon degus with Pfizer's sorbinil.
    Datiles MB; Fukui H
    Curr Eye Res; 1989 Mar; 8(3):233-7. PubMed ID: 2523284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NIH conference. Aldose reductase and complications of diabetes.
    Cogan DG; Kinoshita JH; Kador PF; Robison G; Datilis MB; Cobo LM; Kupfer C
    Ann Intern Med; 1984 Jul; 101(1):82-91. PubMed ID: 6203454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldose reductase, NADPH and NADP+ in normal, galactose-fed and diabetic rat lens.
    Lee SM; Schade SZ; Doughty CC
    Biochim Biophys Acta; 1985 Sep; 841(3):247-53. PubMed ID: 3927985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetic complications in lens and nerve and their prevention by sulindac or sorbinil: two novel aldose reductase inhibitors.
    Jacobson M; Sharma YR; Cotlier E; Hollander JD
    Invest Ophthalmol Vis Sci; 1983 Oct; 24(10):1426-9. PubMed ID: 6413448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of insulin on aldose reductase activity in the lens of rats with streptozotocin-induced diabetes].
    Nishigami T
    Nippon Ganka Gakkai Zasshi; 1990 Feb; 94(2):128-34. PubMed ID: 2114733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CP-45,634: a novel aldose reductase inhibitor that inhibits polyol pathway activity in diabetic and galactosemic rats.
    Peterson MJ; Sarges R; Aldinger CE; MacDonald DP
    Metabolism; 1979 Apr; 28(4 Suppl 1):456-61. PubMed ID: 122297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The identification of aldose reductase in the pathogenesis of diabetic complications: the background.
    Kador PF; Kinoshita JH
    Diabet Med; 1985 May; 2(3):187-9. PubMed ID: 2952417
    [No Abstract]   [Full Text] [Related]  

  • 17. Aldose reductase inhibition, glomerular metabolism, and diabetic nephropathy.
    Cohen M
    Diabet Med; 1985 May; 2(3):203-6. PubMed ID: 3032499
    [No Abstract]   [Full Text] [Related]  

  • 18. The utilization of 13C and 31P nuclear magnetic resonance spectroscopy in the study of the sorbitol pathway and aldose reductase inhibition in intact rabbit lenses.
    Williams WF; Odom JD
    Exp Eye Res; 1987 Jun; 44(6):717-30. PubMed ID: 3115803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldose reductase in diabetic complications of the eye.
    Kinoshita JH; Fukushi S; Kador P; Merola LO
    Metabolism; 1979 Apr; 28(4 Suppl 1):462-9. PubMed ID: 45423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of aldose reductase inhibitor on experimental diabetic cataract monitored by laser Raman spectroscopy.
    Mizuno A; Nozawa H; Yaginuma T; Matsuzaki H; Ozaki Y; Iriyama K
    Exp Eye Res; 1987 Jul; 45(1):185-6. PubMed ID: 3115805
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.